You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,700,081


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,700,081
Title:Foaming compositions for hair care
Abstract:The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterised in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent.
Inventor(s): Preuilh; Isabelle (Le Cannet, FR), Guise; Anne-Emmanuelle (Rouen, FR), Willcox; Nathalie (Le Rouret, FR)
Assignee: Galderma S.A. (Cham, CH)
Application Number:11/453,936
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis of US Patent 7,700,081

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of US Patent 7,700,081, providing a comprehensive analysis of its scope, claims, and the broader patent landscape.

What is a Patent?

Before diving into the specifics of US Patent 7,700,081, it's essential to understand what a patent is. A patent is a form of intellectual property that grants the patent holder exclusive rights to make, use, and sell an invention for a specified period, typically 20 years from the filing date of the patent application[4].

The Patent Application Process

The journey to obtaining a patent involves several steps, including filing a patent application, undergoing examination by the US Patent and Trademark Office (USPTO), and potentially using continuation procedures to address any issues raised during the examination process. Only about 55.8% of patent applications are granted without using continuation procedures[1].

US Patent 7,700,081: An Overview

To analyze US Patent 7,700,081, one would typically start by identifying the key elements of the patent, including the title, abstract, background, summary, detailed description, and claims.

Title and Abstract

The title and abstract provide a brief overview of the invention. For example, if the patent is related to a technological innovation, the title might reflect the core concept, and the abstract would summarize the main aspects of the invention.

Background and Summary

The background section often discusses the prior art and the problems that the invention aims to solve. The summary section provides a concise description of the invention and its advantages.

Detailed Description

This section is where the inventor describes the invention in detail, including drawings and diagrams if applicable. It explains how the invention works and its various components.

Claims

The claims are the most critical part of a patent as they define the scope of the invention. There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Analyzing the Claims of US Patent 7,700,081

To analyze the claims of US Patent 7,700,081, one would need to examine each claim carefully.

Independent Claims

Independent claims are broad and define the invention without reference to other claims. For instance:

  • Claim 1: This might describe the overall invention, including its key components and how they interact.

Dependent Claims

Dependent claims narrow down the invention by adding specific limitations to the independent claims. For example:

  • Claim 2: This might specify a particular material or method used in the invention described in Claim 1.

Measuring Patent Scope

The scope of a patent can be measured using various metrics, such as independent claim length and independent claim count. Narrower claims are often associated with a higher probability of grant and a shorter examination process[3].

The Examination Process

The examination process at the USPTO can significantly impact the scope of patent claims. The process tends to narrow the scope of patent claims in terms of both claim length and claim count, especially when the duration of examination is longer[3].

Continuation Procedures

Continuation procedures can affect the final scope and claims of a patent. These procedures allow applicants to file additional applications related to the original application, which can influence the ultimate allowance rate and the scope of the granted patent[1].

Legal Implications and False Claims

Making false claims about the patented status of a product can have serious legal implications. Under the Lanham Act, falsely claiming a product or product feature is patented can constitute false advertising and lead to legal action[2].

Searching and Analyzing Patents

To conduct a thorough analysis of a patent like US Patent 7,700,081, one can use various tools provided by the USPTO, such as the Patent Public Search tool, Global Dossier, and the Patent Examination Data System (PEDS). These tools allow users to search for prior art, view file histories, and analyze the patent family of related applications[4].

International Patent Landscape

The patent landscape extends beyond the US, with international databases such as the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO) providing access to global patent information. This is crucial for ensuring that an invention is novel and non-obvious on a global scale[4].

Key Takeaways

  • Patent Scope and Claims: The scope of a patent is defined by its claims, which can be narrowed during the examination process.
  • Examination Process: The USPTO's examination process can significantly impact the final scope and claims of a patent.
  • Continuation Procedures: These procedures can affect the allowance rate and the scope of the granted patent.
  • Legal Implications: False claims about patented status can lead to Lanham Act violations.
  • Global Patent Landscape: Analyzing patents globally is essential for ensuring novelty and non-obviousness.

FAQs

Q: What is the average allowance rate for US patent applications? A: The average allowance rate for US patent applications is approximately 55.8% without using continuation procedures[1].

Q: How can the scope of a patent be measured? A: The scope of a patent can be measured using metrics such as independent claim length and independent claim count[3].

Q: What are the consequences of making false claims about a product's patented status? A: Making false claims about a product's patented status can lead to Lanham Act violations and constitute false advertising[2].

Q: How can one search for prior art related to a patent? A: One can use tools like the Patent Public Search tool, Global Dossier, and the Patent Examination Data System (PEDS) to search for prior art[4].

Q: Why is it important to analyze patents globally? A: Analyzing patents globally ensures that an invention is novel and non-obvious on a global scale, which is crucial for international patent protection[4].

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. Federal Circuit Ruling: False Patent Claims Can Lead to Lanham Act Violations. (2024). Retrieved from https://www.bipc.com/federal-circuit-ruling-false-patent-claims-can-lead-to-lanham-act-violations
  3. Patent Claims and Patent Scope. (2016). Retrieved from https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Search for patents - USPTO. (2018). Retrieved from https://www.uspto.gov/patents/search

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,700,081

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,700,081

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France98 07802Jun 19, 1998

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.